iRadimed
IRMD
69 hedge funds and large institutions have $87.1M invested in iRadimed in 2020 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 27 reducing their positions, and 5 closing their positions.
120% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 5
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
8% more funds holding
Funds holding: 64 → 69 (+5)
2.16% more ownership
Funds ownership: 32.12% → 34.28% (+2.2%)
1% more capital invested
Capital invested by funds: $86.3M → $87.1M (+$848K)
26% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NTCM
Nine Ten Capital Management
Chicago,
Illinois
|
+$3.5M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$2.24M |
| 3 |
Renaissance Technologies
New York
|
+$2.19M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.15M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$818K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nuveen
Charlotte,
North Carolina
|
-$1.67M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$874K |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$674K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$563K |
| 5 |
Squarepoint
New York
|
-$348K |
IRMD Hedge Fund Activity: Q1 2020 in Review
69 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q1 2020, worth a combined $87.1M — up 0.98% from $86.3M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new IRMD positions and 5 closed out — a net gain of 6 holders — while 20 added to existing stakes and 27 trimmed.
The largest buyer was Nine Ten Capital Management, adding an estimated $3.5M. The largest seller was Nuveen, exiting entirely with an estimated $1.67M sold.
- 69 institutional investors held iRadimed (IRMD) as of Q1 2020, up from 64 in Q4 2019.
- Funds reported $87.1M of iRadimed stock for Q1 2020, up 0.98% quarter-over-quarter.
- 11 funds opened new iRadimed positions in Q1 2020 and 5 closed out, a net change of +6 holders.
- The largest iRadimed buyer in Q1 2020 was Nine Ten Capital Management, an estimated $3.5M added.
- The largest iRadimed seller in Q1 2020 was Nuveen, an estimated $1.67M sold.
Based on aggregated 13F filings for Q1 2020.